advanced search
Steven Kaufman
Global Executive Specializing in Drug Delivery Systems
Portal Instruments

Is this your profile?

About

Steven Kaufman is a distinguished executive in the drug delivery industry with more than 21 years of experience delivering innovative solutions to pharmaceutical and biotechnology companies. As Portal Instruments’ Chief Commercial Officer, he brings extensive expertise in combination products and self-injection technologies. Prior to joining Portal Instruments in November 2024, Mr Kaufman held executive leadership positions in strategy, marketing and business development at several industry-recognised organisations, including Stevanato Group, Bespak and SHL Medical.

Throughout his career, he has successfully led international teams and driven business growth through strategic partnerships, intellectual property development and competitive positioning. His subject matter expertise spans the full spectrum of drug delivery systems, including autoinjectors, pen injectors, wearable devices, inhalers and other combination products. In addition, he has a comprehensive understanding of fill-finish, primary containers, training devices, tooling, equipment and final assembly.

Mr Kaufman completed his International Master of Business Administration studies with an emphasis on marketing and international business at the National Chengchi University in Taiwan (2003–2006) and completed his undergraduate studies at Western University in Canada (1987–1991).

Contributions

#133_May_2022_OM_Fig2
INTERVIEW
INTERVIEW: STEVEN KAUFMAN, STEVANATO GROUP, & MICHAEL EARL, OWEN MUMFORD
In this exclusive interview, Steven Kaufman of Stevanato Group, and Michael Earl of Owen Mumford, talked with us about their companies' recent major agreement for the manufacturing and provision of prefillable syringes for the advanced two-step, single-use autoinjector, Aidaptus®.

More contributions

INDUSTRIALISATION
LEVERAGING INTEGRATION THROUGHOUT A DRUG DELIVERY SYSTEM PROJECT
Steven Kaufman and Adam Stops describe how an integrated offering can help customers at each phase of a drug delivery system project.
INTERVIEW
INTERVIEW WITH STEVEN KAUFMAN, STEVANATO & URI BARUCH, CDP
Steven Kaufman and Uri Baruch discuss the recently announced collaboration between their two companies to accelerate the development of a new variable-dose, cartridge-based pen injector platform for diabetes.
WEARABLES
CAN WEARABLE DEVICES BRIDGE THE GAP BETWEEN PEN INJECTOR AND PUMP?
Steven Kaufman and Paolo Golfetto explore the potential for wearable injectors to be disruptive technologies in the drug delivery market.
INTERVIEW
STEVEN R KAUFMAN, BESPAK
Steven Kaufman is Global Business Development Lead at Bespak Europe Ltd, responsible for business development activities related to injectable devices such as auto-injectors and wearable injection systems.
PREFILLED SYRINGES
OVERCOMING THE CHALLENGES: COMBINING INJECTABLE DRUG WITH SELF-INJECTION DEVICE
Steven Kaufman talks about a broad range of challenges that biopharmaceutical companies and their partners will likely face on the road to taking their biologics, biosimilars, generic injectables and even biobetters to market in combination products.
Top